Dabrafenib (GSK2118436)

TypeName: Business Offer
Category:
Offer Date:2018/09/29
Country: United States
Summary: Dabrafenib (GSK2118436) is a mutant BRAFV600 specific inhibitor with IC50 of 0.8 nM, with 4- and 6-fold less potency against B-Raf(wt) and c-Raf, respectively.
https://www.bocsci.com/dabrafenib-gsk2118436-cas-1195765-45-7-item-454193.html
Description: [RequestDescription]
OfferId: 2148
Name:Alex Brown
Telphone:
Categories